1. [P1–043]: ELENBECESTAT, A NOVEL ORAL BACE INHIBITOR, HAS NO CLINICALLY MEANINGFUL EFFECT ON QTC INTERVAL UP TO A SUPRATHERAPEUTIC DOSE OF 200 MG. (1st July 2017) Authors: Lai, Robert YK.; Darpo, Borje; Dayal, Satish; Hall, Nancy; Chang, Min‐Kun; Albala, Bruce; Ferry, Jim; Rege, Bhaskar Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 5 Page Start: P250 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. [P2–003]: ELENBECESTAT PHARMACOKINETIC DRUG‐DRUG INTERACTIONS INDICATED NO DOSAGE ADJUSTMENTS REQUIRED FOR MOST CONCOMITANT TREATMENTS. (1st July 2017) Authors: Albala, Bruce; Lai, Robert YK.; Aluri, Jagadeesh; Boyd, Peter; Chang, Min‐Kun; Dayal, Satish; Ferry, Jim; Rege, Bhaskar Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 12 Page Start: P605 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Adjunctive Perampanel Oral Suspension in Pediatric Patients From ≥2 to <12 Years of Age With Epilepsy: Pharmacokinetics, Safety, Tolerability, and Efficacy. (April 2019) Authors: Renfroe, J. Ben; Mintz, Mark; Davis, Ronald; Ferreira, Jose; Dispoto, Sharon; Ferry, Jim; Umetsu, Yuko; Rege, Bhaskar; Majid, Oneeb; Hussein, Ziad; Laurenza, Antonio Journal: Journal of child neurology Issue: Volume 34:Number 5(2019:May) Page Start: 284 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Changes in perampanel levels during de‐induction: Simulations following carbamazepine discontinuation. (11th June 2020) Authors: Schuck, Edgar; Ferry, Jim; Gidal, Barry; Hussein, Ziad Journal: Acta neurologica Scandinavica Issue: Volume 142:Number 2(2020) Page Start: 131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Concentration–effect relationships with perampanel in patients with pharmacoresistant partial‐onset seizures. Issue 8 (17th June 2013) Authors: Gidal, Barry E.; Ferry, Jim; Majid, Oneeb; Hussein, Ziad Journal: Epilepsia Issue: Volume 54:Issue 8(2013:Aug.) Page Start: 1490 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Concentration–Response Modeling of ECG Data From Early‐Phase Clinical Studies as an Alternative Clinical and Regulatory Approach to Assessing QT Risk — Experience From the Development Program of Lemborexant. (4th August 2016) Authors: Murphy, Patricia J.; Yasuda, Sanae; Nakai, Kenya; Yoshinaga, Takashi; Hall, Nancy; Zhou, Meijian; Aluri, Jagadeesh; Rege, Bhaskar; Moline, Margaret; Ferry, Jim; Darpo, Borje Journal: Journal of clinical pharmacology Issue: Volume 57:Number 1(2017) Page Start: 96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Impact of perampanel on pharmacokinetics of concomitant antiepileptics in patients with partial‐onset seizures: pooled analysis of clinical trials. (10th May 2016) Authors: Majid, Oneeb; Laurenza, Antonio; Ferry, Jim; Hussein, Ziad Journal: British journal of clinical pharmacology Issue: Volume 82:Number 2(2016:Aug.) Page Start: 422 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P4‐657: POPULATION PHARMACOKINETIC/PHARMACODYNAMIC ANALYSES OF BAN2401 IN PATIENTS WITH EARLY ALZHEIMER'S DISEASE: CORRELATION OF BAN2401 EXPOSURE, PET STANDARD UPTAKE VALUE RATIO, AND COGNITIVE OUTCOMES. (1st July 2019) Authors: Schuck, Edgar L.; Reyderman, Larisa; Hayato, Seiichi; Takenaka, Osamu; Swanson, Chad J.; Lai, Robert YK.; Hussein, Ziad; Ferry, Jim Journal: Alzheimer's & dementia Issue: Volume 15:Supplement 7(2019)Part 30 Page Start: P1582 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Pharmacokinetic/pharmacodynamic drug–drug interactions of avatrombopag when coadministered with dual or selective CYP2C9 and CYP3A interacting drugs. (20th February 2018) Authors: Nomoto, Maiko; Zamora, Cynthia A.; Schuck, Edgar; Boyd, Peter; Chang, Min‐Kun; Aluri, Jagadeesh; Siu, Y. Amy; Lai, W. George; Yasuda, Sanae; Ferry, Jim; Rege, Bhaskar Journal: British journal of clinical pharmacology Issue: Volume 84:Number 5(2018:Nov.) Page Start: 952 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Pharmacokinetics, Pharmacodynamics, and Safety of the Dual Orexin Receptor Antagonist Lemborexant: Findings From Single‐Dose and Multiple‐Ascending‐Dose Phase 1 Studies in Healthy Adults. Issue 2 (28th May 2020) Authors: Landry, Ishani; Nakai, Kenya; Ferry, Jim; Aluri, Jagadeesh; Hall, Nancy; Lalovic, Bojan; Moline, Margaret L. Journal: Clinical pharmacology in drug development Issue: Volume 10:Issue 2(2021) Page Start: 153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗